Evidence map›Paper›PMID 40489055›Full record

ReviewPharmacological reports : PR2025

Residence time in drug discovery: current insights and future perspectives.

Szymon K Kordylewski, Ryszard Bugno, Sabina Podlewska

Abstract readReview
In one paragraph

Review in Pharmacological reports : PR, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Decoding Prolonged Residence Time of 5-HTJournal of chemical information and modeling · 2026
    Article
  4. Article
  5. Review
  6. Frontiers in cellular and infection microbiology · 2026
    Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Szymon K KordylewskiMaj Institute of Pharmacology Polish Academy of Sciences, Smętna 12, Kraków, 31-343, Poland. kordyl@if-pan.krakow.pl.ORCID https://orcid.org/0000-0003-1147-4837
Ryszard BugnoMaj Institute of Pharmacology Polish Academy of Sciences, Smętna 12, Kraków, 31-343, Poland.
Sabina PodlewskaMaj Institute of Pharmacology Polish Academy of Sciences, Smętna 12, Kraków, 31-343, Poland. smusz@if-pan.krakow.pl.ORCID https://orcid.org/0000-0002-2891-5603

Funding

Narodowe Centrum Nauki OPUS 2023/49/B/NZ7/03340
6 · The paper itself

Abstract

The temporal stability of ligand-receptor complexes is increasingly acknowledged as a critical factor in drug discovery, influencing both efficacy and pharmacodynamics. Although the relationship between the duration of compound action and complex stability can be traced back to Paul Ehrlich's 19th-century doctrine Corpora non agunt nisi fixata, its significance has gained renewed attention in recent years. This review comprehensively examines the concept of residence time (RT). We first summarize key ligand binding models (lock-and-key, induced-fit, and conformational selection) and delve into various perspectives on how RT impacts functional outcomes. Furthermore, we discuss experimental methods for measuring RT, highlighting both radioligand and non-radioligand approaches. The growing interest in RT has spurred advancements in computational techniques, particularly molecular dynamics simulations, which utilize diverse strategies to observe dissociation events. We outline these molecular dynamics-based methods, their theoretical foundations, and provide examples of their application in assessing RT. Finally, we highlight molecular determinants of prolonged RT, focusing primarily on G protein-coupled receptors (GPCRs) while also incorporating relevant data from other receptor classes.

Indexed as

Drug DiscoveryReceptors, G-Protein-CoupledAnimalsHumansLigandsMolecular Dynamics SimulationProtein BindingLigandsReceptors, G-Protein-CoupledG protein-coupled receptorsLigand kineticsMolecular dynamicsResidence time

Identifiers

PMID40489055
PMCPMC12241192

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.